NCT05968326
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected Pancreatic Ductal Adenocarcinoma treatment 2 recruiting NCT04789486
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer treatment 1 / 2 recruiting NCT02125136
Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer No drug interventions treatment 2 completed NCT02047513
Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer treatment 2 completed NCT02657330
Study of SBP-101 in Pancreatic Cancer treatment 1 completed NCT06119776
Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Before and After Study No drug interventions Not Available Not Available recruiting NCT04793932
Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) No drug interventions treatment 2 unknown_status NCT02723331
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates treatment 2 active_not_recruiting NCT04662879
Early Detection Initiative for Pancreatic Cancer No drug interventions screening Not Available enrolling_by_invitation NCT06481397
OSCAR I STUDY - The ONCObind CTC Removal Study No drug interventions treatment Not Available recruiting NCT04990609
EUS-RFA PANCARDINAL-1 Trial No drug interventions treatment 2 recruiting NCT03549000
A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies. No drug interventions treatment 1 terminated NCT06261359
A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma treatment 2 recruiting NCT04083599
GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid Tumors treatment 1 / 2 recruiting NCT06040541
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors No drug interventions treatment 1 recruiting NCT04575363
RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer No drug interventions diagnostic Not Available recruiting NCT05168254
Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT05201729
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT02782182
Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study treatment 1 terminated NCT05706129
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT06026410
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors treatment 1 recruiting NCT04883450
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03977233
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer treatment 2 recruiting NCT06147154
Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients No drug interventions Not Available Not Available completed NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS No drug interventions treatment 1 recruiting NCT03811652
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT03032913
Diagnostic Accuracy of Circulating Tumor Cells (CTCs) and Onco-exosome Quantification in the Diagnosis of Pancreatic Cancer - PANC-CTC No drug interventions Not Available Not Available completed NCT06361030
Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer treatment 2 not_yet_recruiting NCT05605522
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours No drug interventions treatment 1 recruiting NCT04622423
Advanced Therapies for Liver Metastases No drug interventions Not Available Not Available recruiting NCT06044064
"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD)" - A Prospective Pilot Observational Study No drug interventions Not Available Not Available not_yet_recruiting NCT05669287
Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics No drug interventions diagnostic Not Available recruiting NCT05853198
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability No drug interventions diagnostic Not Available recruiting NCT04365049
Nab-Paclitaxel and Gemcitabine Plus Camrelizumab and Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma Not Available Not Available recruiting NCT06122896
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals No drug interventions screening 0 recruiting NCT05642962
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) treatment 1 / 2 recruiting NCT05218889
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer treatment 1 / 2 recruiting NCT05845801
Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT05262855
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma diagnostic 2 recruiting NCT04700488
Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC) No drug interventions diagnostic Not Available recruiting NCT05947825
Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients treatment 2 not_yet_recruiting NCT05727020
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT05132244
Monitoring and Managing Glucose Levels in People With Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT06151223
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT05355298
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer treatment 1 / 2 recruiting NCT05275985
68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma No drug interventions diagnostic Not Available unknown_status NCT06445062
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors treatment 1 / 2 recruiting NCT05895214
Mesopancreas Study in Pancreatic Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT06515587
Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer No drug interventions screening Not Available recruiting NCT04605237
Pancreatic Cancer Recurrence in the Netherlands No drug interventions Not Available Not Available recruiting NCT05631574
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer No drug interventions treatment 1 recruiting NCT02787187
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended? No drug interventions treatment Not Available completed NCT04046887
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC) treatment 1 terminated NCT06214533
Celiac plExus Block to Reduce OpioID Consumption Following Hepato-pancreato-biliary Mini-invasive Surgery treatment Not Available not_yet_recruiting NCT05983133
A Study of SGN-EGFRd2 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT04793633
Evaluating LINFU™: A Noninvasive Method for Collecting Pancreatic Cells for the Early Detection of Pancreatic Cancer No drug interventions Not Available Not Available enrolling_by_invitation NCT04779151
Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab treatment 2 suspended NCT06128551
Study of RMC-6291 in Combination With RMC-6236 in Participants With Advanced KRAS G12C Mutant Solid Tumors No drug interventions treatment 1 recruiting NCT04291651
UCSF PANC Cyst Registry No drug interventions Not Available Not Available recruiting NCT06305247
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT03890198
A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma No drug interventions treatment 0 terminated NCT06060405
Durvalumab and Oleclumab in Resectable PDAC treatment 2 recruiting NCT02929797
Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer treatment 0 unknown_status NCT02050997
Plasma Biomarkers P-DAC, V1 No drug interventions Not Available Not Available terminated NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT03820661
High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma No drug interventions diagnostic Not Available unknown_status NCT05042128
The ASCEND Study: Gemcitabine and Nab-Paclitaxel With CEND-1/LSTA1 or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 active_not_recruiting NCT04310111
EUS-RFA for Unresectable Pancreatic Cancer No drug interventions treatment Not Available completed NCT05257993
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer treatment 1 recruiting NCT04189393
Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery No drug interventions Not Available Not Available unknown_status NCT04802993
Survival Among Patients With Pancreatic Cancer Depending on Surgical Resection Rate No drug interventions Not Available Not Available completed NCT06005493
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05476978
Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions No drug interventions Not Available Not Available completed NCT02042378
A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation treatment 2 completed NCT01879878
Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial] No drug interventions treatment Not Available unknown_status NCT04262388
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation treatment 2 withdrawn NCT06041009
Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations No drug interventions Not Available Not Available recruiting NCT03806309
Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 recruiting NCT06428409
A Clinical Study of MK-2870 Alone or With Chemotherapy to Treat Gastrointestinal Cancers (MK-9999-02A) treatment 1 / 2 recruiting NCT01962909
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer No drug interventions diagnostic 0 terminated NCT04726956
A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC No drug interventions Not Available Not Available unknown_status NCT04580485
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors treatment 1 completed NCT06492915
Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 not_yet_recruiting NCT06275737
POP-UP: a Single-arm, Two-cohort Study: Trimodal Prehab for Upper GI and Pancreatic Cancer No drug interventions other Not Available recruiting NCT03851237
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy No drug interventions diagnostic 1 recruiting NCT01096732
Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) treatment 2 terminated NCT03374852
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer treatment 2 withdrawn NCT02414100
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy No drug interventions Not Available Not Available withdrawn NCT02767700
NGS and TME for Evidence-based Treatment of Pancreatic Cancer No drug interventions Not Available Not Available completed NCT02757859
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery No drug interventions treatment Not Available recruiting NCT06015659
ZN-c3 + Gemcitabine in Pancreatic Cancer treatment 2 recruiting NCT01676259
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer treatment 2 unknown_status NCT05431270
Dose Escalation/Expansion Study of PT199 (an Anti-CD73 mAb) Administered Alone and in Combination With a PD-1 Inhibitor (the MORNINGSTAR Study) treatment 1 recruiting NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells treatment 1 recruiting NCT02981342
A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma treatment 2 completed NCT06115499
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer treatment 2 / 3 recruiting NCT04632199
Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer. No drug interventions diagnostic 1 withdrawn NCT06345599
PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study) treatment 1 / 2 not_yet_recruiting NCT06344299
Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available completed NCT03973736
Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study No drug interventions Not Available Not Available completed NCT03138213
Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy No drug interventions treatment Not Available unknown_status NCT02498613
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors treatment 2 active_not_recruiting NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors treatment 1 / 2 recruiting NCT04975217
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer treatment 0 recruiting NCT05462717
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT06320717
AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT06015724
Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer treatment 2 recruiting NCT05851924
A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC) treatment 2 recruiting NCT03951324
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study No drug interventions Not Available Not Available unknown_status NCT05048524
Peri-operative SLOG for Localized Pancreatic Cancer treatment 2 recruiting NCT03267316
A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors treatment 1 / 2 completed NCT05846516
A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC (KISIMA-02) treatment 1 recruiting NCT04025216
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers treatment 1 terminated NCT01911416
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer treatment Not Available withdrawn NCT05641896
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers No drug interventions diagnostic 2 recruiting NCT02440958
Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial No drug interventions treatment 2 completed NCT06287463
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway No drug interventions treatment 1 / 2 recruiting NCT03317886
Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer No drug interventions treatment 3 unknown_status NCT04634539
Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer treatment 1 active_not_recruiting NCT05783622
Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT05955157
Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma treatment 2 / 3 recruiting NCT04483726
Distal Pancreatectomy, Minimally Invasive or Open, for Malignancy (DIPLOMA) No drug interventions other Not Available active_not_recruiting NCT03979066
Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma treatment 2 terminated NCT05336266
A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma supportive_care 0 active_not_recruiting NCT04596865
Recurrence After Whipple's (RAW) Study No drug interventions Not Available Not Available completed NCT05799274
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer No drug interventions diagnostic 1 recruiting NCT05634720
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer No drug interventions treatment 4 recruiting NCT03481920
A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer treatment 0 terminated NCT03767582
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. treatment 1 / 2 recruiting NCT04969731
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer treatment 3 recruiting NCT03486327
Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions No drug interventions diagnostic 2 terminated NCT04115527
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma. No drug interventions treatment Not Available active_not_recruiting NCT04797676
Effects of Different Methods of PDAC Specimen Acquisition on Primary Cell Culture and Application No drug interventions Not Available Not Available unknown_status NCT03517176
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer treatment 1 completed NCT06478862
Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy treatment 2 recruiting NCT06122480
Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma No drug interventions treatment Not Available recruiting NCT04927780
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer treatment 3 recruiting NCT01942629
Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas No drug interventions Not Available Not Available unknown_status NCT03525392
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. treatment 1 terminated NCT04164992
Endoscopic Ultrasound Radiofrequency Ablation (EUS-RFA) of Not-resectable Pancreatic Cancer No drug interventions treatment Not Available unknown_status NCT05955092
Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT06131840
A Study of PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00588367
CT Pancreas Perfusion No drug interventions Not Available Not Available completed NCT06388967
Pancreatic Cancer Detection Consortium No drug interventions Not Available Not Available recruiting NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT04111172
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma No drug interventions treatment 2 suspended NCT06079346
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer No drug interventions treatment 2 / 3 recruiting NCT06168812
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer treatment 2 recruiting NCT05048810
Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma No drug interventions diagnostic Not Available completed NCT06302881
Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available active_not_recruiting NCT06084481
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 No drug interventions treatment 1 recruiting NCT06218914
A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation No drug interventions treatment 1 recruiting NCT03257150
A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer No drug interventions treatment Not Available completed NCT02575508
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT02677038
Olaparib in Treating Patients With Stage IV Pancreatic Cancer treatment 2 completed NCT03291938
IACS-010759 in Advanced Cancers No drug interventions treatment 1 completed NCT06276803
The LINFU® U.S. Registry for the in the General Population Without Risk Factors No drug interventions Not Available Not Available not_yet_recruiting NCT04400903
Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer No drug interventions Not Available Not Available terminated NCT05726864
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05296421
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer No drug interventions basic_science Not Available recruiting NCT05964621
Venous Thromboembolism in Primary Pancreatic Tumour Resection No drug interventions Not Available Not Available recruiting NCT04712721
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. No drug interventions other 0 terminated NCT06048484
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma treatment 2 recruiting NCT06077487
Ketamine-assisted Therapy for Patients With Pancreatic Ductal Adenocarcinoma supportive_care 4 recruiting NCT03908333
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT03415854
Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) treatment 2 completed NCT05915351
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) treatment 2 recruiting NCT03687853
Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery No drug interventions prevention Not Available unknown_status NCT05546853
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma treatment 1 recruiting NCT04827953
Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer treatment 1 / 2 active_not_recruiting NCT05314998
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature treatment 3 not_yet_recruiting NCT04146298
Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer treatment 1 / 2 recruiting NCT01580397
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer treatment 2 completed NCT02926183
Study of NAC of GA Therapy for Patients With BRPC treatment 2 unknown_status NCT04999761
AB122 Platform Study treatment 1 recruiting NCT04306861
Novel MRI Techniques for Pancreatic Cancer No drug interventions Not Available Not Available withdrawn NCT05632328
AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC treatment 2 recruiting NCT03794128
A Study of Personalized Neoantigen Cancer Vaccines No drug interventions Not Available Not Available completed NCT06528093
A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy treatment 1 not_yet_recruiting NCT05432193
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) treatment 1 active_not_recruiting NCT05482893
PT886 For Treatment of Patients With Metastatic/Advanced Gastric, Gastroesophageal Junction and Pancreatic Adenocarcinoma (the TWINPEAK Study) treatment 1 / 2 recruiting NCT05365893
PHL Treatment in Pancreatic Cancer treatment 0 recruiting NCT05254171
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer treatment 2 / 3 recruiting NCT04954378
Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer No drug interventions Not Available Not Available completed NCT03693378
A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups No drug interventions Not Available Not Available completed NCT03592888
DC Vaccine in Pancreatic Cancer No drug interventions treatment 1 completed NCT04469556
Pancreatic Adenocarcinoma Signature Stratification for Treatment treatment 2 active_not_recruiting NCT04970056
Pancreatic Cancer Early Detection Consortium No drug interventions Not Available Not Available recruiting NCT01188785
Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas treatment 1 completed NCT05737615
PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 No drug interventions diagnostic 1 recruiting NCT06147037
A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours No drug interventions treatment 1 recruiting NCT04913337
Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT03634332
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC treatment 2 unknown_status NCT06199752
Synergistic Immunomodulatory Effect of Synbiotics Pre and Postoperative Resection of Pancreatic Ductal Adenocarcinoma No drug interventions supportive_care 4 completed NCT05584852
Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT03221400
PEN-866 in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT05611359
Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer No drug interventions treatment Not Available not_yet_recruiting NCT03865875
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program No drug interventions health_services_research Not Available unknown_status NCT03435770
Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms No drug interventions treatment Not Available unknown_status NCT05440942
Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 recruiting NCT05708599
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer No drug interventions basic_science Not Available recruiting NCT04449406
Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers No drug interventions Not Available Not Available recruiting NCT01013649
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery treatment 3 active_not_recruiting NCT06287749
French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC) Not Available Not Available not_yet_recruiting NCT05346536
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) No drug interventions other Not Available unknown_status NCT03852836
Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images No drug interventions diagnostic Not Available terminated NCT05727319
Advances in Imaging to Assess Response in Pancreatic Cancer (AIR-PANC) No drug interventions Not Available Not Available recruiting NCT06330441
Pancreatic Cancer Screening in a Population at High Risk No drug interventions screening Not Available recruiting NCT03770117
Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease No drug interventions Not Available Not Available completed NCT04853017
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02527434
Study of Tremelimumab in Patients With Advanced Solid Tumors treatment 2 completed NCT04976634
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) treatment 2 recruiting NCT00669734
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery treatment 1 active_not_recruiting NCT05692596
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics No drug interventions Not Available Not Available recruiting NCT04752696
Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 active_not_recruiting NCT01280058
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer treatment 2 completed NCT00878163
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery treatment 1 active_not_recruiting NCT03697239
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer treatment 1 / 2 withdrawn NCT05977322
A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. treatment 1 recruiting NCT06549725
Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening No drug interventions screening Not Available not_yet_recruiting NCT03410030
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) treatment 1 / 2 completed NCT05289830
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer supportive_care 2 terminated NCT04257448
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer treatment 1 / 2 active_not_recruiting NCT03444948
A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma No drug interventions treatment Not Available suspended NCT04211948
Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer No drug interventions treatment Not Available recruiting NCT02607826
Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors No drug interventions supportive_care Not Available unknown_status NCT03316326
S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer treatment 2 unknown_status NCT06467565
NALIRIFOX as Induction Therapy in LAPC treatment 2 recruiting NCT05209074
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma treatment 1 recruiting NCT06574620
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment No drug interventions basic_science Not Available not_yet_recruiting NCT03012282
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer No drug interventions other Not Available terminated NCT03608631
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation treatment 1 active_not_recruiting NCT04406831
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer No drug interventions Not Available Not Available recruiting NCT04565327
Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma No drug interventions diagnostic 2 terminated NCT03432676
Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic Cancer treatment 2 withdrawn NCT01547260
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer treatment 1 / 2 completed NCT04862260
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma treatment 0 active_not_recruiting NCT01431794
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma treatment 1 / 2 terminated NCT05031494
A Study to Assess YH003 in Combination With Toripalimab(Anti-PD-1 mAb) Injection in Patients With Cancers treatment 2 active_not_recruiting NCT06151691
Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach No drug interventions Not Available Not Available not_yet_recruiting NCT03496662
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) treatment 1 / 2 completed NCT04042480
A Study of SGN-CD228A in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03727880
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma treatment 2 recruiting NCT02570529
Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy No drug interventions treatment 4 withdrawn NCT05630989
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy Not Available Not Available recruiting NCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers treatment 1 not_yet_recruiting NCT02790944
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer No drug interventions Not Available Not Available completed NCT03915444
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma treatment 2 active_not_recruiting NCT04692740
Chlorambucil in Metastatic PDAC Patients Bearing a Germ Line DNA Defects Repair Mutations (SALE Trial) treatment 2 active_not_recruiting NCT04794140
A Clinical Study to Evaluated Which Number of Passes of EUS-FNB is Better for Culturing Primary Cells of PDAC No drug interventions treatment Not Available unknown_status NCT04852367
PanDox: Targeted Doxorubicin in Pancreatic Tumours basic_science 1 withdrawn NCT05132504
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer treatment 2 recruiting NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors diagnostic 2 recruiting NCT04134468
MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma treatment 2 withdrawn NCT04480268
PAXG Out in the Country treatment 4 recruiting NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection No drug interventions diagnostic 2 not_yet_recruiting NCT04662112
Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma No drug interventions treatment 1 / 2 active_not_recruiting NCT01983410
A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma No drug interventions Not Available Not Available recruiting NCT02426281
Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma treatment 2 completed NCT02259114
A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) treatment 1 completed NCT00307723
Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer treatment 1 / 2 terminated NCT01658943
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy treatment 2 completed NCT05141643
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer No drug interventions diagnostic 0 recruiting NCT04477343
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma treatment 1 recruiting NCT05303090
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer treatment 1 recruiting NCT02959164
Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma treatment 1 completed NCT04740164
A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP No drug interventions treatment Not Available completed NCT06105021
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT05867121
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-Care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT01526135
Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma treatment 3 completed NCT02626520
Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla treatment 2 terminated NCT05074472
A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors treatment 1 / 2 completed NCT02456051
Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients No drug interventions Not Available Not Available terminated NCT06573398
Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC treatment 2 not_yet_recruiting NCT01608711
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 treatment 2 completed NCT02933307
Continuous Monitoring on the General Ward No drug interventions prevention Not Available completed NCT01478685
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 completed NCT04146441
Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma treatment 2 completed NCT02310230
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy No drug interventions diagnostic Not Available completed NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT02750657
Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection No drug interventions Not Available Not Available active_not_recruiting NCT05475366
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures No drug interventions diagnostic Not Available recruiting NCT02993731
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma treatment 3 completed NCT00902291
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer treatment 2 completed NCT06447662
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. treatment 1 recruiting NCT03403101
The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer treatment 2 unknown_status NCT02150746
Circulating Tumor Cells in Operative Blood No drug interventions Not Available Not Available completed NCT00226746
Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer treatment 2 withdrawn NCT02658214
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors treatment 1 completed NCT02817308
Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas No drug interventions diagnostic Not Available unknown_status NCT01413451
Amatuximab for High Mesothelin Cancers treatment 0 terminated NCT03513705
Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1) No drug interventions treatment Not Available completed NCT05723978
Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study. No drug interventions Not Available Not Available completed NCT02653313
Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer No drug interventions treatment 1 / 2 completed NCT03432624
Detection of MicroRNA-25 in the Diagnosis of Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT05621824
A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS No drug interventions Not Available Not Available not_yet_recruiting NCT05489458
Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy No drug interventions Not Available Not Available unknown_status NCT01394120
Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer No drug interventions treatment 2 unknown_status NCT03500068
Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study. No drug interventions basic_science Not Available unknown_status NCT00471146
Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. treatment 3 completed NCT02928081
Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma No drug interventions treatment Not Available unknown_status NCT01808638
Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) treatment 1 / 2 completed NCT02451384
According CTC to Compare the Influences of Different Methods to Remove the PDAC No drug interventions treatment Not Available unknown_status NCT02529579
Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer treatment 1 / 2 unknown_status NCT05288205
Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation treatment 1 / 2 recruiting NCT02243007
Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer treatment 2 terminated NCT05293496
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors treatment 1 recruiting NCT06182072
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) treatment 1 recruiting NCT04045496
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT04121286
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China No drug interventions treatment 1 recruiting NCT02715804
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma treatment 3 terminated